A Phase 1, Open-Label Study in Healthy Subjects to Evaluate the Absolute Bioavailability of AG-221 by a Microtracer Approach.
| Published in: | Oncology & Therapy Vol. 8; no. 1; pp. 91 - 103 |
|---|---|
| Main Authors: | , , , , , |
| Format: | Journal Article |
| Published: |
Springer Nature
Jun2020
|
| Online Access: | View this record in EBSCOhost |